<?xml version="1.0" encoding="UTF-8"?>
<p id="p0135">Cytosolic AhR levels and target genes, as well as AhR levels in the nucleus, might be useful markers of COVID-19 patient prognosis, based on previous studies reporting that AhR levels have been used for the diagnosis and prognosis in several aggressive tumors and multiple sclerosis patients (
 <xref rid="bib179" ref-type="bibr">Wheeler et al., 2017</xref>). The contribution of innate versus adaptive immune cells to lung pathology is still under investigation, as many inflammatory mediators are implicated (
 <xref rid="bib43" ref-type="bibr">Esser and Rannug, 2015</xref>). Excessive or non-effective host immune responses due to long-term xenobiotic exposures or viral attacks can impair T cells and monocytes functionality, burden lung pathology and immunodeficiency, as observed in critical COVID-19 patients (
 <xref rid="bib196" ref-type="bibr">D Zhou et al., 2020</xref>).
</p>
